Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30.
Pelser
Colleen
C
Infections & Immunoepidemiology Branch, Division of Cancer Epidemiology & Genetics, National Cancer Institute, National Institutes of Health, Rockville, Maryland, USA. goedertj@mail.nih.gov.
Middeldorp
Jaap
J
Mbulaiteye
Sam M
SM
Lauria
Carmela
C
Messina
Angelo
A
Viviano
Enza
E
Romano
Nino
N
Vitale
Francesco
F
Goedert
James J
JJ